Compliance with European Medicines Agency guideline
Dear all,
I would like to ask whether Acrobat Reader digital signature “certificates” meet the requirements for electronic signatures in clinical studies, in compliance with the EMA guidance (Guideline on Computerised Systems and Electronic Data in Clinical Trials, page 15).
I have pasted the relevant text from page 15.
Additionally, do you know if there is any official documentation from Acrobat Reader that confirms compliance with these requirements?
Thank you very much in advance for your assistance.
Best regards,
Bente
4.8. Electronic signatures
The system should include functionality to:
• authenticate the signatory, i.e. establish a high degree of certainty that a record was signed by
the claimed signatory;
• ensure non-repudiation, i.e. that the signatory cannot later deny having signed the record;
• ensure an unbreakable link between the electronic record and its signature, i.e. that the contents
of a signed (approved) version of a record cannot later be changed by anyone without the
signature being rendered visibly invalid;
• provide a timestamp, i.e. that the date, time, and time zone when the signature was applied is
recorded.
Electronic signatures can further be divided into two groups depending on whether the identity of the
signatory is known in advance, i.e. signatures executed in 'closed' and in 'open' systems.
For 'closed' systems, which constitute the majority of systems used in clinical trials and which are
typically provided by the responsible party or by their respective service provider, the system owner
knows the identity of all users and signatories and grants and controls their access rights to the system.
Regulation (EU) No 910/2014 ('eIDAS') on electronic identification and trust services for electronic
transactions is not applicable for 'closed' systems ('eIDAS' article 2.2). The electronic signature
functionality in these systems should be proven during system validation to meet the expectations
mentioned above.
For 'open' systems, the signatories (and users) are not known in advance. For sites located in the EU,
electronic signatures should meet the requirements defined in the 'eIDAS' regulation. Sites located in
third countries should use electronic or digital signature solutions compliant with local regulations and
proven to meet the expectations mentioned above.
Irrespective of the media used, in case a signature is applied on a different document or only on part of
a document (e.g. signature page), there should still be an unbreakable link between the electronic
document to be signed and the document containing the signature.
